{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:38:06Z","timestamp":1793140686782,"version":"4.5.0"},"reference-count":158,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000065","name":"NIH National Institute of Neurological Disorders and Stroke","doi-asserted-by":"crossref","award":["R01NS122226"],"award-info":[{"award-number":["R01NS122226"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000065","name":"NIH National Institute of Neurological Disorders and Stroke","doi-asserted-by":"crossref","award":["R01NS122226"],"award-info":[{"award-number":["R01NS122226"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000065","name":"NIH National Institute of Neurological Disorders and Stroke","doi-asserted-by":"crossref","award":["R01NS122226"],"award-info":[{"award-number":["R01NS122226"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"DOI":"10.1186\/s40478-026-02221-1","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T12:04:53Z","timestamp":1773230693000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Effects of chemogenetic inhibition of serotonergic raphe-striatal neurons on L-DOPA-induced behaviors and neurochemistry in a rat model of Parkinson\u2019s disease"],"prefix":"10.1186","volume":"14","author":[{"given":"Carla N.","family":"Budrow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis-Daniel","family":"Bernal-Conde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivette M.","family":"Sandoval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Galfano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Grezenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Velazquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Marmion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eden","family":"Flores-Barrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shruti","family":"Venkatesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Coyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Meyers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayla","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Holden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuei Yuan","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher R.","family":"Bishop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredric P.","family":"Manfredsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,11]]},"reference":[{"issue":"6","key":"2221_CR1","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1007\/s11011-019-00462-9","volume":"34","author":"TS Adu","year":"2019","unstructured":"Adu TS, Mabandla MV (2019) Effects of bromelain on motor responses following intra-medial forebrain bundle 6-OHDA injection in rat model of parkinsonism. Metab Brain Dis 34(6):1557\u20131564","journal-title":"Metab Brain Dis"},{"key":"2221_CR2","doi-asserted-by":"crossref","unstructured":"Al-Kassmy J, Alsalmi M, Kang W, Palayew M, Huot P (2025) Recent and on-goingtrials for the treatment of levodopa-induced dyskinesia: a review of the clinical trialdatabases. Neurodegenerative Dis Manage 1\u201310","DOI":"10.1080\/17582024.2025.2528557"},{"issue":"2","key":"2221_CR3","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1172\/JCI90132","volume":"127","author":"C Alcacer","year":"2017","unstructured":"Alcacer C, Andreoli L, Sebastianutto I, Jakobsson J, Fieblinger T, Cenci MA (2017) Chemogenetic stimulation of striatal projection neurons modulates responses to Parkinson\u2019s disease therapy. J Clin Invest 127(2):720\u2013734","journal-title":"J Clin Invest"},{"issue":"10","key":"2221_CR4","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.3390\/cells9102265","volume":"9","author":"F Altwal","year":"2020","unstructured":"Altwal F, Moon C, West AR, Steiner H (2020) The multimodal serotonergic agent vilazodone inhibits L-DOPA-induced gene regulation in striatal projection neurons and associated dyskinesia in an animal model of Parkinson\u2019s disease. Cells 9(10):2265","journal-title":"Cells"},{"issue":"6","key":"2221_CR5","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1006\/nbdi.1999.0259","volume":"6","author":"M Andersson","year":"1999","unstructured":"Andersson M, Hilbertson A, Cenci MA (1999) Striatal fosB expression is causally linked with l-DOPA-induced abnormal involuntary movements and the associated upregulation of striatal prodynorphin mRNA in a rat model of Parkinson\u2019s disease. Neurobiol Dis 6(6):461\u2013474","journal-title":"Neurobiol Dis"},{"issue":"3","key":"2221_CR6","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0304-3940(95)11817-G","volume":"195","author":"R Arai","year":"1995","unstructured":"Arai R, Karasawa N, Geffard M, Nagatsu I (1995) l-DOPA is converted to dopamine in serotonergic fibers of the striatum of the rat: a double-labeling immunofluorescence study. Neurosci Lett 195(3):195\u2013198. https:\/\/doi.org\/10.1016\/0304-3940(95)11817-G","journal-title":"Neurosci Lett"},{"issue":"2","key":"2221_CR7","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/0006-8993(94)91511-3","volume":"667","author":"R Arai","year":"1994","unstructured":"Arai R, Karasawa N, Geffard M, Nagatsu T, Nagatsu I (1994) Immunohistochemical evidence that central serotonin neurons produce dopamine from exogenous l-DOPA in the rat, with reference to the involvement of aromatic l-amino acid decarboxylase. Brain Res 667(2):295\u2013299. https:\/\/doi.org\/10.1016\/0006-8993(94)91511-3","journal-title":"Brain Res"},{"issue":"1","key":"2221_CR8","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0006-8993(95)01281-8","volume":"706","author":"R Arai","year":"1996","unstructured":"Arai R, Karasawa N, Nagatsu I (1996) Aromatic L-amino acid decarboxylase is present in serotonergic fibers of the striatum of the rat. A double-labeling immunofluorescence study. Brain Res 706(1):177\u2013179","journal-title":"Brain Res"},{"issue":"4","key":"2221_CR9","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/S0306-4522(03)00219-7","volume":"119","author":"A Balcioglu","year":"2003","unstructured":"Balcioglu A, Zhang K, Tarazi FI (2003) Dopamine depletion abolishes apomorphine-and amphetamine-induced increases in extracellular serotonin levels in the striatum of conscious rats: a microdialysis study. Neuroscience 119(4):1045\u20131053","journal-title":"Neuroscience"},{"key":"2221_CR10","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/978-1-4939-3271-9_14","volume":"1382","author":"MJ Benskey","year":"2016","unstructured":"Benskey MJ, Manfredsson FP (2016) Intraparenchymal stereotaxic delivery of rAAV and special considerations in vector handling. Methods Mol Biol 1382:199\u2013215. https:\/\/doi.org\/10.1007\/978-1-4939-3271-9_14","journal-title":"Methods Mol Biol"},{"issue":"1","key":"2221_CR11","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1089\/hgtb.2015.117","volume":"27","author":"MJ Benskey","year":"2016","unstructured":"Benskey MJ, Sandoval IM, Manfredsson FP (2016) Continuous collection of adeno-associated virus from producer cell medium significantly increases total viral yield. Hum Gene Ther Methods 27(1):32\u201345. https:\/\/doi.org\/10.1089\/hgtb.2015.117","journal-title":"Hum Gene Ther Methods"},{"key":"2221_CR12","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/0022-510X(73)90175-5","volume":"20","author":"H Bernheimer","year":"1973","unstructured":"Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F (1973) Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci 20:415\u2013455","journal-title":"J Neurol Sci"},{"issue":"2","key":"2221_CR13","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/s1353-8020(98)00013-3","volume":"4","author":"W Birkmayer","year":"1998","unstructured":"Birkmayer W, Hornykiewicz O (1998) The effect of l-3, 4-dihydroxyphenylalanine (=DOPA) on akinesia in parkinsonism. Parkinsonism Relat Disord 4(2):59\u201360. https:\/\/doi.org\/10.1016\/s1353-8020(98)00013-3","journal-title":"Parkinsonism Relat Disord"},{"issue":"6","key":"2221_CR14","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1111\/j.1460-9568.2012.08202.x","volume":"36","author":"C Bishop","year":"2012","unstructured":"Bishop C, George JA, Buchta W, Goldenberg AA, Mohamed M, Dickinson SO, Eissa S, Eskow Jaunarajs KL (2012) Serotonin transporter inhibition attenuates l-DOPA-induced dyskinesia without compromising l-DOPA efficacy in hemi-parkinsonian rats. Eur J Neurosci 36(6):2839\u20132848. https:\/\/doi.org\/10.1111\/j.1460-9568.2012.08202.x","journal-title":"Eur J Neurosci"},{"issue":"7","key":"2221_CR15","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1002\/jnr.21978","volume":"87","author":"C Bishop","year":"2009","unstructured":"Bishop C, Krolewski DM, Eskow KL, Barnum CJ, Dupre KB, Deak T, Walker PD (2009) Contribution of the striatum to the effects of 5\u2010HT1A receptor stimulation in L\u2010DOPA\u2010treated hemiparkinsonian rats. J Neurosci Res 87(7):1645\u20131658","journal-title":"J Neurosci Res"},{"issue":"2","key":"2221_CR16","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1124\/jpet.104.066365","volume":"310","author":"C Bishop","year":"2004","unstructured":"Bishop C, Tessmer JL, Ullrich T, Rice KC, Walker PD (2004) Serotonin 5-HT2A receptors underlie increased motor behaviors induced in dopamine-depleted rats by intrastriatal 5-HT2A\/2C agonism. J Pharmacol Exp Ther 310(2):687\u2013694","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"2221_CR17","doi-asserted-by":"publisher","first-page":"837","DOI":"10.3390\/cells12060837","volume":"12","author":"C Budrow","year":"2023","unstructured":"Budrow C, Elder K, Coyle M, Centner A, Lipari N, Cohen S, Bishop C (2023) Broad serotonergic actions of vortioxetine as a promising avenue for the treatment of L-DOPA-induced dyskinesia. Cells 12(6):837","journal-title":"Cells"},{"issue":"8","key":"2221_CR18","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.parkreldis.2011.05.012","volume":"17","author":"C B\u00e9dard","year":"2011","unstructured":"B\u00e9dard C, Wallman MJ, Pourcher E, Gould PV, Parent A, Parent M (2011) Serotonin and dopamine striatal innervation in Parkinson\u2019s disease and Huntington\u2019s chorea. Parkinsonism Relat Disord 17(8):593\u2013598","journal-title":"Parkinsonism Relat Disord"},{"issue":"30","key":"2221_CR19","doi-asserted-by":"publisher","first-page":"8011","DOI":"10.1523\/JNEUROSCI.2079-07.2007","volume":"27","author":"T Carlsson","year":"2007","unstructured":"Carlsson T, Carta M, Winkler C, Bj\u00f6rklund A, Kirik D (2007) Serotonin neuron transplants exacerbate L-DOPA-induced dyskinesias in a rat model of Parkinson\u2019s disease. J Neurosci 27(30):8011\u20138022","journal-title":"J Neurosci"},{"key":"2221_CR20","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.neuroscience.2011.07.070","volume":"198","author":"M Carta","year":"2011","unstructured":"Carta M, Bezard E (2011) Contribution of pre-synaptic mechanisms to L-DOPA-induced dyskinesia. Neuroscience 198:245\u2013251","journal-title":"Neuroscience"},{"issue":"8","key":"2221_CR21","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1007\/s00702-018-1865-5","volume":"125","author":"M Carta","year":"2018","unstructured":"Carta M, Bj\u00f6rklund A (2018) The serotonergic system in L-DOPA-induced dyskinesia: pre-clinical evidence and clinical perspective. J Neural Transm 125(8):1195\u20131202","journal-title":"J Neural Transm"},{"issue":"7","key":"2221_CR22","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1093\/brain\/awm082","volume":"130","author":"M Carta","year":"2007","unstructured":"Carta M, Carlsson T, Kirik D, Bj\u00f6rklund A (2007) Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats. Brain 130(7):1819\u20131833","journal-title":"Brain"},{"key":"2221_CR23","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/S0079-6123(08)00922-9","volume":"172","author":"M Carta","year":"2008","unstructured":"Carta M, Carlsson T, Munoz A, Kirik D, Bjorklund A (2008) Serotonin-dopamine interaction in the induction and maintenance of l-DOPA-induced dyskinesias. Prog Brain Res 172:465\u2013478. https:\/\/doi.org\/10.1016\/S0079-6123(08)00922-9","journal-title":"Prog Brain Res"},{"key":"2221_CR24","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3389\/fneur.2014.00078","volume":"5","author":"M Carta","year":"2014","unstructured":"Carta M, Tronci E (2014) Serotonin system implication in L-DOPA-induced dyskinesia: from animal models to clinical investigations. Front Neurol 5:78","journal-title":"Front Neurol"},{"key":"2221_CR25","doi-asserted-by":"publisher","first-page":"105930","DOI":"10.1016\/j.nbd.2022.105930","volume":"176","author":"I Castela","year":"2023","unstructured":"Castela I, Casado-Polanco R, Rubio YVW, da Silva JA, Marquez R, Pro B, Moratalla R, Redgrave P, Costa RM, Obeso J, Hernandez LF (2023) Selective activation of striatal indirect pathway suppresses levodopa induced-dyskinesias. Neurobiol Dis 176:105930","journal-title":"Neurobiol Dis"},{"issue":"3","key":"2221_CR26","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1002\/mds.27959","volume":"35","author":"MA Cenci","year":"2020","unstructured":"Cenci MA, Riggare S, Pahwa R, Eidelberg D, Hauser RA (2020) Dyskinesia matters. Mov Disord 35(3):392\u2013396. https:\/\/doi.org\/10.1002\/mds.27959","journal-title":"Mov Disord"},{"key":"2221_CR27","doi-asserted-by":"publisher","first-page":"109027","DOI":"10.1016\/j.neuropharm.2022.109027","volume":"210","author":"MA Cenci","year":"2022","unstructured":"Cenci MA, Skovg\u00e5rd K, Odin P (2022) Non-dopaminergic approaches to the treatment of motor complications in Parkinson\u2019s disease. Neuropharmacology 210:109027","journal-title":"Neuropharmacology"},{"key":"2221_CR28","doi-asserted-by":"crossref","unstructured":"Cenci MA, Konradi C (2010) Maladaptive striatal plasticity in L-DOPA-induced dyskinesia.Progress Brain Res 183:209\u2013233","DOI":"10.1016\/S0079-6123(10)83011-0"},{"issue":"2","key":"2221_CR29","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/S0306-4522(98)00217-6","volume":"88","author":"JW Chang","year":"1999","unstructured":"Chang JW, Wachtel SR, Young D, Kang UJ (1999) Biochemical and anatomical characterization of forepaw adjusting steps in rat models of Parkinson\u2019s disease: studies on medial forebrain bundle and striatal lesions. Neuroscience 88(2):617\u2013628","journal-title":"Neuroscience"},{"issue":"3","key":"2221_CR30","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1002\/jnr.23879","volume":"95","author":"D Chen","year":"2017","unstructured":"Chen D, Fu W, Zhuang W, Lv C, Li F, Wang X (2017) Therapeutic effects of intranigral transplantation of mesenchymal stem cells in rat models of Parkinson\u2019s disease. J Neurosci Res 95(3):907\u2013917","journal-title":"J Neurosci Res"},{"key":"2221_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.615491","author":"V Chenouard","year":"2021","unstructured":"Chenouard V, Remy S, Tesson L, M\u00e9noret S, Ouisse L-H, Cherifi Y, Anegon I (2021) Advances in genome editing and application to the generation of genetically modified rat models. Front Genetics. https:\/\/doi.org\/10.3389\/fgene.2021.615491","journal-title":"Front Genetics"},{"issue":"3","key":"2221_CR32","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1093\/brain\/awaa020","volume":"143","author":"Y Chu","year":"2020","unstructured":"Chu Y, Bartus RT, Manfredsson FP, Olanow CW, Kordower JH (2020) Long-term post-mortem studies following neurturin gene therapy in patients with advanced Parkinson\u2019s disease. Brain 143(3):960\u2013975. https:\/\/doi.org\/10.1093\/brain\/awaa020","journal-title":"Brain"},{"key":"2221_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2022.173393","author":"SR Cohen","year":"2022","unstructured":"Cohen SR, Terry ML, Coyle M, Wheelis E, Centner A, Smith S, Bishop C (2022) The multimodal serotonin compound Vilazodone alone, but not combined with the glutamate antagonist Amantadine, reduces l-DOPA-induced dyskinesia in hemiparkinsonian rats. Pharmacol Biochem Behav. https:\/\/doi.org\/10.1016\/j.pbb.2022.173393","journal-title":"Pharmacol Biochem Behav"},{"key":"2221_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2023.148381","author":"MM Conti Mazza","year":"2023","unstructured":"Conti Mazza MM, Centner A, Werner DF, Bishop C (2023) Striatal serotonin transporter gain-of-function in L-DOPA-treated, hemi-parkinsonian rats. Brain Res. https:\/\/doi.org\/10.1016\/j.brainres.2023.148381","journal-title":"Brain Res"},{"key":"2221_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuropharm.2013.09.017","volume":"77","author":"MM Conti","year":"2014","unstructured":"Conti MM, Ostock CY, Lindenbach D et al (2014) Effects of prolonged selective serotonin reuptake inhibition on the development and expression of L-DOPA-induced dyskinesia in hemi-parkinsonian rats. Neuropharmacology 77:1\u20138","journal-title":"Neuropharmacology"},{"issue":"2","key":"2221_CR36","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1002\/mds.870050203","volume":"5","author":"AR Crossman","year":"1990","unstructured":"Crossman AR (1990) A hypothesis on the pathophysiological mechanisms that underlie levodopa\u2010or dopamine agonist\u2010induced dyskinesia in Parkinson\u2019s disease: implications for future strategies in treatment. Mov Disord 5(2):100\u2013108","journal-title":"Mov Disord"},{"issue":"1","key":"2221_CR37","first-page":"135","volume":"1158","author":"A Dekundy","year":"2007","unstructured":"Dekundy A, Lundblad M, Danysz W, Cenci MA (2007) The differential effects of 5-HT1A receptor stimulation on dopamine receptor-mediated abnormal involuntary movements and rotations in the primed hemiparkinsonian rat. Brain Res 1158(1):135\u2013143","journal-title":"Brain Res"},{"issue":"2","key":"2221_CR38","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1006\/exnr.2002.7891","volume":"175","author":"R Deumens","year":"2002","unstructured":"Deumens R, Blokland A, Prickaerts J (2002) Modeling Parkinson\u2019s disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway. Exp Neurol 175(2):303\u2013317","journal-title":"Exp Neurol"},{"issue":"3","key":"2221_CR39","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/j.1755-5949.2010.00135.x","volume":"16","author":"G Di Giovanni","year":"2010","unstructured":"Di Giovanni G, Esposito E, Di Matteo V (2010) Role of serotonin in central dopamine dysfunction. CNS Neurosci Ther 16(3):179\u2013194","journal-title":"CNS Neurosci Ther"},{"key":"2221_CR40","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/S0079-6123(08)00921-7","volume":"172","author":"V Di Matteo","year":"2008","unstructured":"Di Matteo V, Pierucci M, Esposito E, Crescimanno G, Benigno A, Di Giovanni G (2008) Serotonin modulation of the basal ganglia circuitry: therapeutic implication for Parkinson\u2019s disease and other motor disorders. Prog Brain Res 172:423\u2013463","journal-title":"Prog Brain Res"},{"issue":"12","key":"2221_CR41","doi-asserted-by":"publisher","first-page":"6947","DOI":"10.1128\/JVI.07232-11","volume":"86","author":"MA DiMattia","year":"2012","unstructured":"DiMattia MA, Nam HJ, Van Vliet K, Mitchell M, Bennett A, Gurda BL, Agbandje-McKenna M (2012) Structural insight into the unique properties of adeno-associated virus serotype 9. J virol 86(12):6947\u20136958","journal-title":"J virol"},{"issue":"8","key":"2221_CR42","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1016\/j.neuropharm.2008.08.031","volume":"55","author":"KB Dupre","year":"2008","unstructured":"Dupre KB, Eskow KL, Barnum CJ, Bishop C (2008) Striatal 5-HT1A receptor stimulation reduces D1 receptor-induced dyskinesia and improves movement in the hemiparkinsonian rat. Neuropharmacology 55(8):1321\u20131328","journal-title":"Neuropharmacology"},{"issue":"2","key":"2221_CR43","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.expneurol.2011.02.012","volume":"229","author":"KB Dupre","year":"2011","unstructured":"Dupre KB, Ostock CY, Jaunarajs KLE, Button T, Savage LM, Wolf W, Bishop C (2011) Local modulation of striatal glutamate efflux by serotonin 1A receptor stimulation in dyskinetic, hemiparkinsonian rats. Exp Neurol 229(2):288\u2013299","journal-title":"Exp Neurol"},{"issue":"11","key":"2221_CR44","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1001\/jamaneurol.2015.1921","volume":"72","author":"JG English","year":"2015","unstructured":"English JG, Roth BL (2015) Chemogenetics\u2014a transformational and translational platform. JAMA Neurol 72(11):1361\u20131366","journal-title":"JAMA Neurol"},{"issue":"7","key":"2221_CR45","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1002\/syn.20630","volume":"63","author":"KL Eskow","year":"2009","unstructured":"Eskow KL, Dupre KB, Barnum CJ, Dickinson SO, Park JY, Bishop C (2009) The role of the dorsal raphe nucleus in the development, expression, and treatment of L-dopa-induced dyskinesia in hemiparkinsonian rats. Synapse 63(7):610\u2013620. https:\/\/doi.org\/10.1002\/syn.20630","journal-title":"Synapse"},{"key":"2221_CR46","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.pbb.2007.05.002","volume":"87","author":"K Eskow","year":"2007","unstructured":"Eskow K, Gupta V, Alam S, Park J, Bishop C (2007) The partial 5-HT1A agonist buspirone reduces the expression and development of l-DOPA-induced dyskinesia in rats and improves l-DOPA efficacy. Pharmacol Biochem Behav 87:306\u2013314","journal-title":"Pharmacol Biochem Behav"},{"key":"2221_CR47","doi-asserted-by":"publisher","first-page":"469","DOI":"10.2147\/JEP.S265282","volume":"13","author":"A Fabbrini","year":"2021","unstructured":"Fabbrini A, Guerra A (2021) Pathophysiological mechanisms and experimental pharmacotherapy for L-dopa-induced dyskinesia. J Exp Pharmacol 13:469","journal-title":"J Exp Pharmacol"},{"issue":"1","key":"2221_CR48","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.neulet.2011.03.088","volume":"496","author":"T Falk","year":"2011","unstructured":"Falk T, Yue X, Zhang S, McCourt AD, Yee BJ, Gonzalez RT, Sherman SJ (2011) Vascular endothelial growth factor-B is neuroprotective in an in vivo rat model of Parkinson\u2019s disease. Neurosci Lett 496(1):43\u201347","journal-title":"Neurosci Lett"},{"key":"2221_CR49","first-page":"268","volume":"19","author":"F Farajdokht","year":"2020","unstructured":"Farajdokht F, Sadigh-Eteghad S, Majdi A, Pashazadeh F, Vatandoust SM, Ziaee M, Mahmoudi J (2020) Serotonergic system modulation holds promise for L-DOPA-induced dyskinesias in hemiparkinsonian rats: a systematic review. EXCLI J 19:268","journal-title":"EXCLI J"},{"key":"2221_CR50","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3389\/fnbeh.2011.00071","volume":"5","author":"M Feyder","year":"2011","unstructured":"Feyder M, Bonito-Oliva A, Fisone G (2011) L-DOPA-induced dyskinesia and abnormal signaling in striatal medium spiny neurons: focus on dopamine D1 receptor-mediated transmission. Front Behav Neurosci 5:71","journal-title":"Front Behav Neurosci"},{"key":"2221_CR51","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.neuroscience.2015.04.027","volume":"298","author":"C Fidalgo","year":"2015","unstructured":"Fidalgo C, Ko WKD, Tronci ELISABETTA, Li Q, Stancampiano ROBERTO, Chuan Q, Carta M (2015) Effect of serotonin transporter blockade on L-DOPA-induced dyskinesia in animal models of Parkinson\u2019s disease. Neuroscience 298:389\u2013396","journal-title":"Neuroscience"},{"issue":"1","key":"2221_CR52","doi-asserted-by":"publisher","first-page":"10068","DOI":"10.1038\/s41598-018-28273-5","volume":"8","author":"T Fieblinger","year":"2018","unstructured":"Fieblinger T, Zanetti L, Sebastianutto I, Breger LS, Quintino L, Lockowandt M, Cenci MA (2018) Striatonigral neurons divide into two distinct morphological-physiological phenotypes after chronic L-DOPA treatment in parkinsonian rats. Sci Rep 8(1):10068","journal-title":"Sci Rep"},{"key":"2221_CR53","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.tics.2014.11.004","volume":"19","author":"AG Fischer","year":"2015","unstructured":"Fischer AG, Jocham G, Ullsperger M (2015) Dual serotonergic signals: a key to understanding paradoxical effects? Trends Cogn Sci 19:21\u201326. https:\/\/doi.org\/10.1016\/j.tics.2014.11.004","journal-title":"Trends Cogn Sci"},{"key":"2221_CR54","doi-asserted-by":"publisher","first-page":"484","DOI":"10.3389\/fnhum.2017.00484","volume":"11","author":"AG Fischer","year":"2017","unstructured":"Fischer AG, Ullsperger M (2017) An update on the role of serotonin and its interplay with dopamine for reward. Front Hum Neurosci 11:484","journal-title":"Front Hum Neurosci"},{"issue":"9","key":"2221_CR55","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1002\/mds.22473","volume":"24","author":"SH Fox","year":"2009","unstructured":"Fox SH, Chuang R, Brotchie JM (2009) Serotonin and Parkinson\u2019s disease: on movement, mood, and madness. Mov Disord 24(9):1255\u20131266","journal-title":"Mov Disord"},{"issue":"2","key":"2221_CR56","doi-asserted-by":"publisher","first-page":"eabe5948","DOI":"10.1126\/sciadv.abe5948","volume":"7","author":"E Fridjonsdottir","year":"2021","unstructured":"Fridjonsdottir E, Shariatgorji R, Nilsson A, Vallianatou T, Odell LR, Schembri LS, Svenningsson P, Fernagut PO, Crossman AR, Bezard E, Andr\u00e9n PE (2021) Mass spectrometry imaging identifies abnormally elevated brain l-DOPA levels and extrastriatal monoaminergic dysregulation in l-DOPA-induced dyskinesia. Sci Adv 7(2):eabe5948. https:\/\/doi.org\/10.1126\/sciadv.abe5948","journal-title":"Sci Adv"},{"issue":"12","key":"2221_CR57","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1093\/brain\/awh290","volume":"127","author":"R de la Fuente-Fern\u00e1ndez","year":"2004","unstructured":"de la Fuente-Fern\u00e1ndez R, Sossi V, Huang Z, Furtado S, Lu JQ, Calne DB, Stoessl AJ (2004) Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson\u2019s disease: implications for dyskinesias. Brain 127(12):2747\u20132754","journal-title":"Brain"},{"key":"2221_CR58","first-page":"553","volume":"29","author":"O Gershanik","year":"1979","unstructured":"Gershanik O, Heikkila R, Duvoisin R (1979) The role of serotonin neurons in the action of L-dopa in an animal model of parkinsonism. Neurology 29:553","journal-title":"Neurology"},{"key":"2221_CR59","doi-asserted-by":"publisher","first-page":"787.e6","DOI":"10.1016\/j.neuron.2018.01.017","volume":"97","author":"AE Girasole","year":"2018","unstructured":"Girasole AE, Lum MY, Nathaniel D, Bair-Marshall CJ, Guenthner CJ, Luo L et al (2018) A subpopulation of striatal neurons mediates levodopa-induced dyskinesia. Neuron 97:787.e6-795.e6. https:\/\/doi.org\/10.1016\/j.neuron.2018.01.017","journal-title":"Neuron"},{"issue":"27","key":"2221_CR60","doi-asserted-by":"publisher","first-page":"e81426","DOI":"10.1371\/journal.pone.0081426","volume":"8","author":"SE Gombash","year":"2013","unstructured":"Gombash SE, Manfredsson FP, Kemp CJ, Kuhn NC, Fleming SM, Egan AE, Grant LM, Ciucci MR, MacKeigan JP, Sortwell CE (2013) Morphological and behavioral impact of AAV2\/5-mediated overexpression of human wildtype alpha-synuclein in the rat nigrostriatal system. PLoS ONE 8(27):e81426. https:\/\/doi.org\/10.1371\/journal.pone.0081426","journal-title":"PLoS ONE"},{"issue":"2","key":"2221_CR61","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/0376-8716(94)01066-T","volume":"37","author":"AA Grace","year":"1995","unstructured":"Grace AA (1995) The tonic\/phasic model of dopamine system regulation: its relevance for understanding how stimulant abuse can alter basal ganglia function. Drug Alcohol Depend 37(2):111\u2013129","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"2221_CR62","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.neuropharm.2011.01.041","volume":"60","author":"LJ Heng","year":"2011","unstructured":"Heng LJ, Markham JA, Hu XT, Tseng KY (2011) Concurrent upregulation of postsynaptic L-type Ca(2+) channel function and protein kinase A signaling is required for the periadolescent facilitation of Ca(2+) plateau potentials and dopamine D1 receptor modulation in the prefrontal cortex. Neuropharmacology 60(6):953\u2013962. https:\/\/doi.org\/10.1016\/j.neuropharm.2011.01.041","journal-title":"Neuropharmacology"},{"issue":"1","key":"2221_CR63","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1212\/WNL.47.1.219","volume":"47","author":"MT Herrero","year":"1996","unstructured":"Herrero MT, Levy R, Ruberg M, Luquin MR, Villares J, Guillen J, Faucheux B, Javoy-Agid F, Guridi J, Agid Y, Obeso JA, Hirsch EC (1996) Consequence of nigrostriatal denervation and L-dopa therapy on the expression of glutamic acid decarboxylase messenger RNA in the pallidum. Neurology 47(1):219\u2013224","journal-title":"Neurology"},{"issue":"6180","key":"2221_CR64","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/334345a0","volume":"334","author":"E Hirsch","year":"1988","unstructured":"Hirsch E, Graybiel AM, Agid YA (1988) Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson\u2019s disease. Nature 334(6180):345\u2013348. https:\/\/doi.org\/10.1038\/334345a0","journal-title":"Nature"},{"issue":"1","key":"2221_CR65","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/mds.25032","volume":"28","author":"EC Hirsch","year":"2013","unstructured":"Hirsch EC, Jenner P, Przedborski S (2013) Pathogenesis of Parkinson\u2019s disease. Mov Disord 28(1):24\u201330","journal-title":"Mov Disord"},{"issue":"6","key":"2221_CR66","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1097\/00004630-199011000-00003","volume":"11","author":"IA Holder","year":"1990","unstructured":"Holder IA, Neely AN (1990) Hageman factor-dependent kinin activation in burns and its theoretical relationship to postburn immunosuppression syndrome and infection. J Burn Care Rehabil 11(6):496\u2013503. https:\/\/doi.org\/10.1097\/00004630-199011000-00003","journal-title":"J Burn Care Rehabil"},{"issue":"4","key":"2221_CR67","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.jchemneu.2003.10.002","volume":"26","author":"JP Hornung","year":"2003","unstructured":"Hornung JP (2003) The human raphe nuclei and the serotonergic system. J Chem Neuroanat 26(4):331\u2013343","journal-title":"J Chem Neuroanat"},{"key":"2221_CR68","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1124\/pr.111.005678","volume":"65","author":"P Huot","year":"2013","unstructured":"Huot P, Johnston TH, Koprich JB, Fox SH, Brotchie JM (2013) The pharmacology of l-DOPA-induced dyskinesia in Parkinson\u2019s Disease. Pharmacol Rev 65:171\u2013222","journal-title":"Pharmacol Rev"},{"key":"2221_CR69","doi-asserted-by":"publisher","first-page":"105491","DOI":"10.1016\/j.nbd.2021.105491","volume":"159","author":"V Iyer","year":"2021","unstructured":"Iyer V, Venkiteswaran K, Savaliya S, Lieu CA, Handly E, Gilmour TP, Subramanian T (2021) The cross-hemispheric nigrostriatal pathway prevents the expression of levodopa-induced dyskinesias. Neurobiol Disease 159:105491","journal-title":"Neurobiol Disease"},{"issue":"1","key":"2221_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41531-019-0096-2","volume":"5","author":"V Iyer","year":"2019","unstructured":"Iyer V, Vo Q, Mell A, Chinniah S, Zenerovitz A, Venkiteswaran K, Kunselman AR, Fang J, Subramanian T (2019) Acute levodopa dosing around-the-clock ameliorates REM sleep without atonia in hemiparkinsonian rats. NPJ Parkinsons Dis 5(1):1\u201311","journal-title":"NPJ Parkinsons Dis"},{"issue":"1","key":"2221_CR71","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1152\/physrev.1992.72.1.165","volume":"72","author":"BL Jacobs","year":"1992","unstructured":"Jacobs BL, Azmitia EC (1992) Structure and function of the brain serotonin system. Physiol Rev 72(1):165\u2013229","journal-title":"Physiol Rev"},{"key":"2221_CR72","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.neubiorev.2017.09.028","volume":"91","author":"A Jager","year":"2018","unstructured":"Jager A, Maas DA, Fricke K, de Vries RB, Poelmans G, Glennon JC (2018) Aggressive behavior in transgenic animal models: a systematic review. Neurosci Biobehav Rev 91:198\u2013217. https:\/\/doi.org\/10.1016\/j.neubiorev.2017.09.028","journal-title":"Neurosci Biobehav Rev"},{"issue":"1","key":"2221_CR73","doi-asserted-by":"publisher","first-page":"4522","DOI":"10.1038\/s41598-019-41088-2","volume":"9","author":"M Jendryka","year":"2019","unstructured":"Jendryka M, Palchaudhuri M, Ursu D, van der Veen B, Liss B, K\u00e4tzel D, Nissen W, Pekcec A (2019) Pharmacokinetic and pharmacodynamic actions of clozapine-N- oxide, clozapine, and compound 21 in DREADD-based chemogenetics in mice. Sci Rep 9(1):4522","journal-title":"Sci Rep"},{"key":"2221_CR74","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/nrn2471","volume":"9","author":"P Jenner","year":"2008","unstructured":"Jenner P (2008) Molecular mechanisms of L-DOPA-induced dyskinesia. Nat Rev Neurosci 9:665\u2013677. https:\/\/doi.org\/10.1038\/nrn2471","journal-title":"Nat Rev Neurosci"},{"key":"2221_CR75","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.omtn.2017.06.011","volume":"15","author":"NM Kanaan","year":"2017","unstructured":"Kanaan NM, Sellnow RC, Boye SL, Coberly B, Bennett A, Agbandje-McKenna M, Sortwell CE, Hauswirth WW, Boye SE, Manfredsson FP (2017) Rationally engineered AAV capsids improve transduction and volumetric spread in the CNS. Mol Ther Nucleic Acids 15:184\u2013197. https:\/\/doi.org\/10.1016\/j.omtn.2017.06.011","journal-title":"Mol Ther Nucleic Acids"},{"key":"2221_CR76","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.neulet.2006.03.059","volume":"402","author":"K Kannari","year":"2006","unstructured":"Kannari K, Shen H, Arai A, Tomiyama M, Baba M (2006) Reuptake of L-DOPA-derived extracellular dopamine in the striatum with dopaminergic denervation via serotonin transporters. Neurosci Lett 402:62\u201365","journal-title":"Neurosci Lett"},{"issue":"3","key":"2221_CR77","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/S0168-0102(98)00040-6","volume":"31","author":"R Katoh-Semba","year":"1998","unstructured":"Katoh-Semba R, Semba R, Takeuchi IK, Kato K (1998) Age-related changes in levels of brain-derived neurotrophic factor in selected brain regions of rats, normal mice and senescence-accelerated mice: a comparison to those of nerve growth factor and neurotrophin-3. Neurosci Res 31(3):227\u2013234","journal-title":"Neurosci Res"},{"issue":"4","key":"2221_CR78","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1172\/JCI46229","volume":"121","author":"MJ Krashes","year":"2011","unstructured":"Krashes MJ, Koda S, Ye C, Rogan SC, Adams AC, Cusher DS, Maratos-Flier E, Roth BL, Lowell BB (2011) Rapid, reversible activation of AgRP neurons drives feeding behavior in mice. J Clin Invest 121(4):1424\u20131428. https:\/\/doi.org\/10.1172\/JCI46229","journal-title":"J Clin Invest"},{"issue":"8","key":"2221_CR79","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1007\/s00702-017-1837-1","volume":"125","author":"K Lanza","year":"2018","unstructured":"Lanza K, Bishop C (2018) Serotonergic targets for the treatment of L-DOPA-induced dyskinesia. J Neural Transm 125(8):1203\u20131216","journal-title":"J Neural Transm"},{"key":"2221_CR80","doi-asserted-by":"publisher","first-page":"113534","DOI":"10.1016\/j.expneurol.2020.113534","volume":"336","author":"K Lanza","year":"2021","unstructured":"Lanza K, Centner A, Coyle M, Del Priore I, Manfredsson FP, Bishop C (2021) Genetic suppression of the dopamine D3 receptor in striatal D1 cells reduces the development of L-DOPA-induced dyskinesia. Exp Neurol 336:113534","journal-title":"Exp Neurol"},{"key":"2221_CR81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/cne.902990102","volume":"299","author":"B Lavoie","year":"1990","unstructured":"Lavoie B, Parent A (1990) Immunohistochemical study of the serotoninergic innervation of the basal ganglia in the squirrel monkey. J Comp Neurol 299:1\u201316","journal-title":"J Comp Neurol"},{"issue":"5","key":"2221_CR82","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1111\/j.1460-9568.2009.06873.x","volume":"30","author":"T Lebouvier","year":"2009","unstructured":"Lebouvier T, Chaumette T, Paillusson S, Duyckaerts C, Bruley des Varannes S, Neunlist M, Derkinderen P (2009) The second brain and Parkinson\u2019s disease. Eur J Neurosci 30(5):735\u2013741","journal-title":"Eur J Neurosci"},{"issue":"10","key":"2221_CR83","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1212\/WNL.0000000000001909","volume":"85","author":"JY Lee","year":"2015","unstructured":"Lee JY, Seo S, Lee JS, Kim HJ, Kim YK, Jeon BS (2015) Putaminal serotonergic innervation: monitoring dyskinesia risk in Parkinson disease. Neurology 85(10):853\u2013860","journal-title":"Neurology"},{"key":"2221_CR84","doi-asserted-by":"publisher","first-page":"449","DOI":"10.4088\/JCP.v57n1002","volume":"57","author":"RJ Leo","year":"1996","unstructured":"Leo RJ (1996) Movement disorders associated with the serotonin selective reuptake inhibitors. J Clin Psychiatry 57:449\u2013454","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"2221_CR85","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/bph.12894","volume":"172","author":"D Lindenbach","year":"2015","unstructured":"Lindenbach D, Palumbo N, Ostock CY, Vilceus N, Conti MM, Bishop C (2015) Side effect profile of 5-HT treatments for Parkinson\u2019s dis- ease and L-DOPA-induced dyskinesia in rats. Br J Pharmacol 172(1):119\u2013130","journal-title":"Br J Pharmacol"},{"issue":"6","key":"2221_CR86","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1111\/j.1471-4159.2009.06556.x","volume":"112","author":"HS Lindgren","year":"2010","unstructured":"Lindgren HS, Andersson DR, Lagerkvist S, Nissbrandt H, Cenci MA (2010) l\u2010DOPA\u2010induced dopamine efflux in the striatum and the substantia nigra in a rat model of Parkinson\u2019s disease: temporal and quantitative relationship to the expression of dyskinesia. J Neurochem 112(6):1465\u20131476","journal-title":"J Neurochem"},{"key":"2221_CR87","doi-asserted-by":"publisher","first-page":"105965","DOI":"10.1016\/j.nbd.2022.105965","volume":"176","author":"N Lipari","year":"2023","unstructured":"Lipari N, Centner A, Glinski J, Cohen S, Manfredsson FP, Bishop C (2023) Characterizing the relationship between L-DOPA-induced-dyskinesia and psychosis-like behaviors in a bilateral rat model of Parkinson\u2019s disease. Neurobiol Dis 176:105965","journal-title":"Neurobiol Dis"},{"issue":"1","key":"2221_CR88","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/0149-7634(94)90039-6","volume":"18","author":"I Lucki","year":"1994","unstructured":"Lucki I, Singh A, Kreiss DS (1994) Antidepressant-like behavioral effects of serotonin receptor agonists. Neurosci Biobehav Rev 18(1):85\u201395","journal-title":"Neurosci Biobehav Rev"},{"issue":"1","key":"2221_CR89","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1046\/j.0953-816x.2001.01843.x","volume":"15","author":"M Lundblad","year":"2002","unstructured":"Lundblad M, Andersson M, Winkler C, Kirik D, Wierup N, Cenci MA (2002) Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson\u2019s disease. Eur J Neurosci 15(1):120\u2013132","journal-title":"Eur J Neurosci"},{"issue":"1","key":"2221_CR90","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0304-3940(03)00295-7","volume":"343","author":"T Maeda","year":"2003","unstructured":"Maeda T, Kannari K, Shen H, Arai A, Tomiyama M, Matsunaga M, Suda T (2003) Rapid induction of serotonergic hyperinnervation in the adult rat striatum with extensive dopaminergic denervation. Neurosci Lett 343(1):17\u201320","journal-title":"Neurosci Lett"},{"issue":"1\u20132","key":"2221_CR91","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.brainres.2005.04.019","volume":"1046","author":"T Maeda","year":"2005","unstructured":"Maeda T, Nagata K, Yoshida Y, Kannari K (2005) Serotonergic hyperinnervation into the dopaminergic denervated striatum compensates for dopamine conversion from exogenously administered l-DOPA. Brain Res 1046(1\u20132):230\u2013233","journal-title":"Brain Res"},{"issue":"4","key":"2221_CR92","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nn.3664","volume":"17","author":"SV Mahler","year":"2014","unstructured":"Mahler SV, Vazey EM, Beckley JT, Keistler CR, McGlinchey EM, Kaufling J, Aston-Jones G (2014) Designer receptors show role for ventral pallidum input to ventral tegmental area in cocaine seeking. Nat Neurosci 17(4):577\u2013585","journal-title":"Nat Neurosci"},{"issue":"12","key":"2221_CR93","doi-asserted-by":"publisher","first-page":"5247","DOI":"10.1523\/JNEUROSCI.23-12-05247.2003","volume":"23","author":"P Mailly","year":"2003","unstructured":"Mailly P, Charpier S, Menetrey A, Deniau JM (2003) Three-dimensional organization of the recurrent axon collateral network of the substantia nigra pars reticulata neurons in the rat. J Neurosci 23(12):5247\u20135257","journal-title":"J Neurosci"},{"key":"2221_CR94","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1002\/cne.903140312","volume":"314","author":"LA Mamounas","year":"1991","unstructured":"Mamounas LA, Mullen CA, O\u2019Hearn E, Molliver ME (1991) Dual serotoninergic projections to forebrain in the rat: morphologically distinct 5-HT axon terminals exhibit differential vulnerability to neurotoxic amphetamine derivatives. J Comp Neurol 314:558\u2013586","journal-title":"J Comp Neurol"},{"key":"2221_CR95","doi-asserted-by":"publisher","first-page":"593572","DOI":"10.3389\/fnagi.2020.593572","volume":"12","author":"FP Manfredsson","year":"2020","unstructured":"Manfredsson FP, Polinski NK, Subramanian T, Boulis N, Wakeman DR, Mandel RJ (2020) The future of GDNF in Parkinson\u2019s disease. Front Aging Neurosci 12:593572. https:\/\/doi.org\/10.3389\/fnagi.2020.593572","journal-title":"Front Aging Neurosci"},{"issue":"3","key":"2221_CR96","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/mt.2009.15","volume":"17","author":"FP Manfredsson","year":"2009","unstructured":"Manfredsson FP, Rising AC, Mandel RJ (2009) AAV9: a potential blood-brain barrier buster. Mol Ther 17(3):403\u2013405","journal-title":"Mol Ther"},{"key":"2221_CR97","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/S0028-3908(97)00035-X","volume":"36","author":"M el Mansari","year":"1997","unstructured":"el Mansari M, Blier P (1997) In vivo electrophysiological characterization of 5-HT receptors in the guinea pig head of caudate nucleus and orbitofrontal cortex. Neuropharmacology 36:577\u2013588. https:\/\/doi.org\/10.1016\/S0028-3908(97)00035-X","journal-title":"Neuropharmacology"},{"key":"2221_CR98","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/0014-2999(94)90316-6","volume":"261","author":"M el Mansari","year":"1994","unstructured":"el Mansari M, Radja F, Ferron A, Reader TA, Molina-Holgado E, Descarries L (1994) Hypersensitivity to serotonin and its agonists in serotonin-hyperinnervated neostriatum after neonatal dopamine denervation. Eur J Pharmacol 261:171\u2013178. https:\/\/doi.org\/10.1016\/0014-2999(94)90316-6","journal-title":"Eur J Pharmacol"},{"issue":"8","key":"2221_CR99","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1002\/mds.26731","volume":"31","author":"R Mart\u00ednez-Fern\u00e1ndez","year":"2016","unstructured":"Mart\u00ednez-Fern\u00e1ndez R, Schmitt E, Martinez-Martin P, Krack P (2016) The hidden sister of motor fluctuations in Parkinson\u2019s disease: a review on nonmotor fluctuations. Mov Disord 31(8):1080\u20131094","journal-title":"Mov Disord"},{"issue":"3","key":"2221_CR100","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/ane.12314","volume":"131","author":"S Mazzucchi","year":"2015","unstructured":"Mazzucchi S, Frosini D, Ripoli A, Nicoletti V, Linsalata G, Bonuccelli U, Ceravolo R (2015) Serotonergic antidepressant drugs and L-dopa-induced dyskinesias in Parkinson\u2019s disease. Acta Neurol Scand 131(3):191\u2013195","journal-title":"Acta Neurol Scand"},{"key":"2221_CR101","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1046\/j.1471-4159.1997.69020791.x","volume":"69","author":"R McQuade","year":"1997","unstructured":"McQuade R, Sharp T (1997) Functional mapping of dorsal and median raphe 5-hydroxytryptamine pathways in forebrain of the rat using microdialysis. J Neurochem 69:791\u2013796","journal-title":"J Neurochem"},{"issue":"11","key":"2221_CR102","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1002\/mds.100","volume":"33","author":"SM Meadows","year":"2018","unstructured":"Meadows SM, Conti MM, Gross L, Chambers NE, Avnor Y, Ostock CY, Lanza K, Bishop C (2018) Diverse serotonin actions of vilazodone reduce l\u20103, 4\u2010dihidroxyphenylalanine\u2013induced dyskinesia in hemi\u2010parkinsonian rats. Mov Disord 33(11):1740\u20131749","journal-title":"Mov Disord"},{"key":"2221_CR103","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3389\/fncir.2014.00021","volume":"8","author":"C Miguelez","year":"2014","unstructured":"Miguelez C, Morera-Herreras T, Torrecilla M, Ruiz-Ortega JA, Ugedo L (2014) Interaction between the 5-HT system and the basal ganglia: functional implication and therapeutic perspective in Parkinson\u2019s disease. Front Neural Circuits 8:21","journal-title":"Front Neural Circuits"},{"issue":"2","key":"2221_CR104","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/0006-8993(94)01210-9","volume":"669","author":"A Mrini","year":"1995","unstructured":"Mrini A, Soucy JP, Lafaille F, Lemoine P, Descarries L (1995) Quantification of the serotonin hyperinnervation in adult rat neostriatum after neonatal 6-hydroxydopamine lesion of nigral dopamine neurons. Brain Res 669(2):303\u2013308","journal-title":"Brain Res"},{"issue":"1","key":"2221_CR105","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.nbd.2010.01.012","volume":"38","author":"S Navailles","year":"2010","unstructured":"Navailles S, Bioulac B, Gross C, De Deurwaerd\u00e8re P (2010) Serotonergic neurons mediate ectopic release of dopamine induced by L-DOPA in a rat model of Parkinson\u2019s disease. Neurobiol Dis 38(1):136\u2013143","journal-title":"Neurobiol Dis"},{"issue":"1","key":"2221_CR106","first-page":"323686","volume":"2012","author":"S Navailles","year":"2012","unstructured":"Navailles S, De Deurwaerdere P (2012) Imbalanced dopaminergic transmission mediated by serotonergic neurons in L\u2010DOPA\u2010induced dyskinesia. Parkinson\u2019s disease 2012(1):323686","journal-title":"Parkinson\u2019s disease"},{"key":"2221_CR107","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.neuroscience.2013.12.029","volume":"260","author":"N Nevalainen","year":"2013","unstructured":"Nevalainen N, Af Bjerken S, Gerhardt GA, Stromberg I (2013) Serotonergic nerve fibers in l-DOPA-derived dopamine release and dyskinesia. Neuroscience 260:73\u201386. https:\/\/doi.org\/10.1016\/j.neuroscience.2013.12.029","journal-title":"Neuroscience"},{"issue":"5","key":"2221_CR108","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1007\/s11064-018-2514-y","volume":"43","author":"A Newman-Tancredi","year":"2018","unstructured":"Newman-Tancredi A, Varney MA, McCreary AC (2018) Effects of the serotonin 5-HT1A receptor biased agonists, F13714 and F15599, on striatal neurotransmitter levels following L-DOPA administration in Hemi-Parkinsonian rats. Neurochem Res 43(5):1035\u20131046. https:\/\/doi.org\/10.1007\/s11064-018-2514-y","journal-title":"Neurochem Res"},{"key":"2221_CR109","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1126\/science.172.3982.487","volume":"172","author":"K Ng","year":"1971","unstructured":"Ng K, Chase T, Colburn R, Kopin I (1971) Dopamine stimulation-induced release from central neurons. Science 172:487\u2013489","journal-title":"Science"},{"key":"2221_CR110","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/bs.irn.2018.08.002","volume":"141","author":"G Pagano","year":"2018","unstructured":"Pagano G, Politis M (2018) Molecular imaging of the serotonergic system in Parkinson\u2019s disease. Int Rev Neurobiol 141:173\u2013210","journal-title":"Int Rev Neurobiol"},{"issue":"3","key":"2221_CR111","doi-asserted-by":"publisher","first-page":"190","DOI":"10.4103\/aian.AIAN_239_17","volume":"20","author":"S Pandey","year":"2017","unstructured":"Pandey S, Srivanitchapoom P (2017) Levodopa-induced dyskinesia: clinical features, pathophysiology, and medical management. Ann Indian Acad Neurol 20(3):190\u2013198. https:\/\/doi.org\/10.4103\/aian.AIAN_239_17","journal-title":"Ann Indian Acad Neurol"},{"key":"2221_CR112","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/0006-8993(82)91119-2","volume":"243","author":"MR Park","year":"1982","unstructured":"Park MR, Gonzales-Vegas JA, Kitai ST (1982) Serotonergic excitation from dorsal raphe stimulation recorded intracellularly from rat caudate-putamen. Brain Res 243:49\u201358. https:\/\/doi.org\/10.1016\/0006-8993(82)91119-2","journal-title":"Brain Res"},{"key":"2221_CR113","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41586-018-0090-6","volume":"557","author":"JG Parker","year":"2018","unstructured":"Parker JG, Marshall JD, Ahanonu B, Wu YW, Kim TH, Grewe BF et al (2018) Diametric neural ensemble dynamics in Parkinsonian and dyskinetic states. Nature 557:177\u2013182. https:\/\/doi.org\/10.1038\/s41586-018-0090-6","journal-title":"Nature"},{"key":"2221_CR114","first-page":"1023","volume":"1022","author":"G Paxinos","year":"1998","unstructured":"Paxinos G, Watson C (1998) A stereotaxic atlas of the rat brain. New York: Acad 1022:1023","journal-title":"New York: Acad"},{"key":"2221_CR115","volume-title":"The rat brain in stereotaxic coordinates: hard","author":"G Paxinos","year":"2006","unstructured":"Paxinos G, Watson C (2006) The rat brain in stereotaxic coordinates: hard, cover. Elsevier","edition":"cover"},{"issue":"6","key":"2221_CR116","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1111\/ejn.14129","volume":"48","author":"AM Penttinen","year":"2018","unstructured":"Penttinen AM, Parkkinen I, Blom S, Kopra J, Andressoo JO, Pitk\u00e4nen K, Voutilainen MH, Saarma M, Airavaara M (2018) Implementation of deep neural networks to count dopamine neurons in substantia nigra. Eur J Neurosci 48(6):2354\u20132361. https:\/\/doi.org\/10.1111\/ejn.14129","journal-title":"Eur J Neurosci"},{"issue":"1","key":"2221_CR117","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1100\/2011\/172893","volume":"11","author":"M Politis","year":"2011","unstructured":"Politis M, Loane C (2011) Serotonergic dysfunction in Parkinson\u2032 s disease and its relevance to disability. Sci World J 11(1):1726\u20131734","journal-title":"Sci World J"},{"issue":"3","key":"2221_CR118","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1172\/JCI71640","volume":"124","author":"M Politis","year":"2014","unstructured":"Politis M, Wu K, Loane C, Brooks DJ, Kiferle L, Turkheimer FE, Piccini P (2014) Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson\u2019s disease patients. J Clin Invest 124(3):1340\u20131349","journal-title":"J Clin Invest"},{"issue":"11","key":"2221_CR119","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1002\/mds.23135","volume":"25","author":"M Politis","year":"2010","unstructured":"Politis M, Wu K, Molloy S, Bain P, Chaudhuri KR, Piccini P (2010) Parkinson\u2019s disease symptoms: the patient\u2019s perspective. Mov Disord 25(11):1646\u20131651. https:\/\/doi.org\/10.1002\/mds.23135","journal-title":"Mov Disord"},{"issue":"10","key":"2221_CR120","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1093\/brain\/awv215","volume":"138","author":"Z Qamhawi","year":"2015","unstructured":"Qamhawi Z, Towey D, Shah B, Pagano G, Seibyl J, Marek K, Pavese N (2015) Clinical correlates of raphe serotonergic dysfunction in early Parkinson\u2019s disease. Brain 138(10):2964\u20132973","journal-title":"Brain"},{"key":"2221_CR121","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/00002826-200201000-00004","volume":"25","author":"L Rampello","year":"2002","unstructured":"Rampello L, Chiechio S, Raffaele R, Vecchio I, Nicoletti F (2002) The SSRI, citalopram, improves bradykinesia in patients with Parkinson\u2019s disease treated with L-dopa. Clin Neuropharmacol 25:21\u201324","journal-title":"Clin Neuropharmacol"},{"issue":"1","key":"2221_CR122","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0197-0186(98)00048-5","volume":"34","author":"T Reader","year":"1999","unstructured":"Reader T (1999) Review article effects of denervation and hyperinnervation on dopamine and serotonin systems in the rat neostriatum: implications for human Parkinsons disease. Neurochem Int 34(1):1\u201321. https:\/\/doi.org\/10.1016\/s0197-0186(98)00048-5","journal-title":"Neurochem Int"},{"issue":"1","key":"2221_CR123","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/j.1749-6632.1995.tb17487.x","volume":"757","author":"TA Reader","year":"1995","unstructured":"Reader TA, Radja F, Dewar KM, Descarriey L (1995) Denervation, hyperinnervation, and interactive regulation of dopamine and serotonin receptors a. Ann N Y Acad Sci 757(1):293\u2013310","journal-title":"Ann N Y Acad Sci"},{"issue":"8","key":"2221_CR124","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1038\/sj.mt.6300227","volume":"15","author":"S Reimsnider","year":"2007","unstructured":"Reimsnider S, Manfredsson FP, Muzyczka N, Mandel RJ (2007) Time course of transgene expression after intrastriatal pseudotyped rAAV2\/1, rAAV2\/2, rAAV2\/5, and rAAV2\/8 transduction in the rat. Mol Ther 15(8):1504\u20131511. https:\/\/doi.org\/10.1038\/sj.mt.6300227","journal-title":"Mol Ther"},{"key":"2221_CR125","doi-asserted-by":"crossref","unstructured":"Robke R, Sans, F, Arbab T, Tunez A, Moore M, Bartsch D, Sch\u00f6nig K, Willuhn I (2025)Optogenetic stimulation of novel Tph2-Cre rats advances insight into serotonin's rolein locomotion, reinforcement, and compulsivity. J Neurosci 45(21):e1424242025","DOI":"10.1523\/JNEUROSCI.1424-24.2025"},{"issue":"4","key":"2221_CR126","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.neuron.2016.01.040","volume":"89","author":"BL Roth","year":"2016","unstructured":"Roth BL (2016) DREADDs for neuroscientists. Neuron 89(4):683\u2013694","journal-title":"Neuron"},{"issue":"3","key":"2221_CR127","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0304-3940(98)00198-0","volume":"245","author":"G Rozas","year":"1998","unstructured":"Rozas G, Liste I, Guerra MJ, Labandeira-Garcia JL (1998) Sprouting of the serotonergic afferents into striatum after selective lesion of the dopaminergic system by MPTP in adult mice. Neurosci Lett 245(3):151\u2013154","journal-title":"Neurosci Lett"},{"issue":"3","key":"2221_CR128","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.nbd.2010.05.001","volume":"39","author":"D Rylander","year":"2010","unstructured":"Rylander D, Iderberg H, Li Q, Dekundy A, Zhang J, Li H, Cenci MA (2010) A mGluR5 antagonist under clinical development improves L-DOPA-induced dyskinesia in parkinsonian rats and monkeys. Neurobiol Dis 39(3):352\u2013361","journal-title":"Neurobiol Dis"},{"issue":"5","key":"2221_CR129","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1002\/ana.22097","volume":"68","author":"D Rylander","year":"2010","unstructured":"Rylander D, Parent M, O\u2019Sullivan SS, Dovero S, Lees AJ, Bezard E, Cenci MA (2010) Maladaptive plasticity of serotonin axon terminals in levodopa\u2010induced dyskinesia. Ann Neurol 68(5):619\u2013628","journal-title":"Ann Neurol"},{"issue":"4","key":"2221_CR130","doi-asserted-by":"publisher","first-page":"102332","DOI":"10.1016\/j.omtn.2024.102332","volume":"35","author":"IM Sandoval","year":"2024","unstructured":"Sandoval IM, Kelley CM, Bernal-Conde LD, Steece-Collier K, Marmion DJ, Davidsson M, Crosson SM, Boye SL, Boye SE, Manfredsson FP (2024) Engineered AAV capsid transport mutants overcome transduction deficiencies in the aged CNS. Mol Ther Nucleic Acids 35(4):102332. https:\/\/doi.org\/10.1016\/j.omtn.2024.102332","journal-title":"Mol Ther Nucleic Acids"},{"key":"2221_CR131","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/978-1-4939-9065-8_6","volume":"1937","author":"IM Sandoval","year":"2019","unstructured":"Sandoval IM, Kuhn NM, Manfredsson FP (2019) Multimodal production of adeno-associated virus. Methods Mol Biol 1937:101\u2013124. https:\/\/doi.org\/10.1007\/978-1-4939-9065-8_6","journal-title":"Methods Mol Biol"},{"issue":"26","key":"2221_CR132","doi-asserted-by":"publisher","first-page":"6995","DOI":"10.1523\/JNEUROSCI.0852-07.2007","volume":"27","author":"E Santini","year":"2007","unstructured":"Santini E, Valjent E, Usiello A, Carta M, Borgkvist A, Girault JA, Fisone G (2007) Critical involvement of cAMP\/DARPP-32 and extracellular signal-regulated protein kinase signaling in L-DOPA-induced dyskinesia. J Neurosci 27(26):6995\u20137005","journal-title":"J Neurosci"},{"issue":"5","key":"2221_CR133","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/nbt811","volume":"21","author":"F Schn\u00fctgen","year":"2003","unstructured":"Schn\u00fctgen F, Doerflinger N, Call\u00e9ja C, Wendling O, Chambon P, Ghyselinck NB (2003) A directional strategy for monitoring Cre-mediated recombination at the cellular level in the mouse. Nat Biotechnol 21(5):562\u2013565. https:\/\/doi.org\/10.1038\/nbt811","journal-title":"Nat Biotechnol"},{"issue":"7","key":"2221_CR134","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.biopsych.2015.02.016","volume":"78","author":"MD Scofield","year":"2015","unstructured":"Scofield MD, Boger HA, Smith RJ, Li H, Haydon PG, Kalivas PW (2015) Gq-DREADD Selectively Initiates Glial Glutamate Release and Inhibits Cue-induced Cocaine Seeking. Biol Psychiatry 78(7):441\u2013451","journal-title":"Biol Psychiatry"},{"issue":"1","key":"2221_CR135","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40478-018-0653-7","volume":"7","author":"RC Sellnow","year":"2019","unstructured":"Sellnow RC, Newman JH, Chambers N, West AR, Steece-Collier K, Sandoval IM, Manfredsson FP (2019) Regulation of dopamine neurotransmission from serotonergic neurons by ectopic expression of the dopamine D2 autoreceptor blocks levodopa-induced dyskinesia. Acta Neuropathol Commun 7(1):1\u201317","journal-title":"Acta Neuropathol Commun"},{"issue":"18","key":"2221_CR136","doi-asserted-by":"publisher","first-page":"3675","DOI":"10.1523\/JNEUROSCI.2936-19.2020","volume":"40","author":"RC Sellnow","year":"2020","unstructured":"Sellnow RC, Steece-Collier K, Altwal F, Sandoval IM, Kordower JH, Collier TJ, Sortwell CE, West AR, Manfredsson FP (2020) Striatal nurr1 facilitates the dyskinetic state and exacerbates levodopa-induced dyskinesia in a rat model of parkinson\u2019s disease. J Neurosci 40(18):3675\u20133691","journal-title":"J Neurosci"},{"issue":"1","key":"2221_CR137","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.pneurobio.2011.10.005","volume":"96","author":"V Sgambato-Faure","year":"2012","unstructured":"Sgambato-Faure V, Cenci MA (2012) Glutamatergic mechanisms in the dyskinesias induced by pharmacological dopamine replacement and deep brain stimulation for the treatment of Parkinson\u2019s disease. Prog Neurobiol 96(1):69\u201386","journal-title":"Prog Neurobiol"},{"issue":"2","key":"2221_CR138","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1037\/bne0000135","volume":"130","author":"KS Smith","year":"2016","unstructured":"Smith KS, Bucci DJ, Luikart BW, Mahler SV (2016) DREADDS: use and application in behavioral neuroscience. Behav Neurosci 130(2):137","journal-title":"Behav Neurosci"},{"key":"2221_CR139","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-022-06078-9","author":"S Smith","year":"2022","unstructured":"Smith S, Sergio J, Coyle M, Elder K, Centner A, Cohen S, Terry M, Lipari N, Glinski J, Wheelis E, Budrow C, Bishop C (2022) The effects of vilazodone, YL-0919 and vortioxetine in hemiparkinsonian rats. Psychopharmacology. https:\/\/doi.org\/10.1007\/s00213-022-06078-9","journal-title":"Psychopharmacology"},{"issue":"1","key":"2221_CR140","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/syn.890010103","volume":"1","author":"JS Sprouse","year":"1987","unstructured":"Sprouse JS, Aghajanian GK (1987) Electrophysiological responses of serotoninergic dorsal raphe neurons to 5-HT1A and 5-HT1B agonists. Synapse 1(1):3\u20139","journal-title":"Synapse"},{"issue":"7","key":"2221_CR141","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/0028-3908(88)90079-2","volume":"27","author":"JS Sprouse","year":"1988","unstructured":"Sprouse JS, Aghajanian GK (1988) Responses of hippocampal pyramidal cells to putative serotonin 5-HT1A and 5-HT1B agonists: a comparative study with dorsal raphe neurons. Neuropharmacology 27(7):707\u2013715","journal-title":"Neuropharmacology"},{"issue":"5","key":"2221_CR142","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1002\/mds.27695","volume":"34","author":"K Steece-Collier","year":"2019","unstructured":"Steece-Collier K, Stancati JA, Collier NJ, Sandoval IM, Mercado NM, Sortwell CE, Collier TJ, Manfredsson FP (2019) Genetic silencing of striatal CaV1.3 prevents and ameliorates levodopa dyskinesia. Mov Disord 34(5):697\u2013707","journal-title":"Mov Disord"},{"key":"2221_CR143","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/0006-8993(90)90851-2","volume":"529","author":"A Stefani","year":"1990","unstructured":"Stefani A, Surmeier DJ, Kitai ST (1990) Serotonin enhances excitability in neostriatal neurons by reducing voltage-dependent potassium currents. Brain Res 529:354\u2013357. https:\/\/doi.org\/10.1016\/0006-8993(90)90851-2","journal-title":"Brain Res"},{"key":"2221_CR144","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0079-6468(08)70083-3","volume":"40","author":"G Subramanian","year":"2002","unstructured":"Subramanian G, Poda G, Jorvig E, Ferguson DM (2002) 4 Molecular modeling of opioid receptor-ligand complexes. Prog Med Chem 40:107\u2013135","journal-title":"Prog Med Chem"},{"issue":"2","key":"2221_CR145","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/0006-8993(91)90635-9","volume":"562","author":"Y Takeuchi","year":"1991","unstructured":"Takeuchi Y, Sawada T, Blunt S, Jenner P, Marsden CD (1991) Effects of 6-hydroxydopamine lesions of the nigrostriatal pathway on striatal serotonin innervation in adult rats. Brain Res 562(2):301\u2013305","journal-title":"Brain Res"},{"issue":"3","key":"2221_CR146","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1097\/00001756-199902250-00034","volume":"10","author":"H Tanaka","year":"1999","unstructured":"Tanaka H, Kannari K, Maeda T, Tomiyama M, Suda T, Matsunaga M (1999) Role of serotonergic neurons in L-DOPA-derived extracellular dopamine in the striatum of 6-OHDA-lesioned rats. NeuroReport 10(3):631\u2013634","journal-title":"NeuroReport"},{"issue":"4","key":"2221_CR147","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.pbb.2005.06.013","volume":"81","author":"JL Taylor","year":"2005","unstructured":"Taylor JL, Bishop C, Walker PD (2005) Dopamine D1 and D2 receptor contributions to L-DOPA-induced dyskinesia in the dopamine-depleted rat. Pharmacol Biochem Behav 81(4):887\u2013893","journal-title":"Pharmacol Biochem Behav"},{"issue":"1","key":"2221_CR148","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1021\/acsptsci.8b00012","volume":"1","author":"KJ Thompson","year":"2018","unstructured":"Thompson KJ, Khajehali E, Bradley SJ, Navarrete JS, Huang XP, Slocum S, Jin J, Liu J, Xiong Y, Olsen RHJ, Diberto JF, Boyt KM, Pina MM, Pati D, Molloy C, Bundgaard C, Sexton PM, Kash TL, Krashes MJ, Christopoulos A, Roth BL, Tobin AB (2018) DREADD agonist 21 Is an effective agonist for muscarinic-based DREADDs in Vitro and in Vivo. ACS Pharmacol Transl Sci 1(1):61\u201372","journal-title":"ACS Pharmacol Transl Sci"},{"key":"2221_CR149","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/0006-8993(79)91016-3","volume":"175","author":"CP Vandermaelen","year":"1979","unstructured":"Vandermaelen CP, Bonduki AC, Kitai ST (1979) Excitation of caudate-putamen neurons following stimulation of the dorsal raphe nucleus in the rat. Brain Res 175:356\u2013361. https:\/\/doi.org\/10.1016\/0006-8993(79)91016-3","journal-title":"Brain Res"},{"issue":"10","key":"2221_CR150","doi-asserted-by":"publisher","first-page":"3859","DOI":"10.1073\/pnas.1310025111","volume":"11","author":"EM Vazey","year":"2014","unstructured":"Vazey EM, Aston-Jones G (2014) Designer receptor manipulations reveal a role of the locus coeruleus noradrenergic system in isoflurane general anesthesia. Proc Natl Acad Sci U S A 11(10):3859\u20133864. https:\/\/doi.org\/10.1073\/pnas.1310025111","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2221_CR151","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.neuint.2016.11.009","volume":"102","author":"Y Vermeiren","year":"2017","unstructured":"Vermeiren Y, De Deyn PP (2017) Targeting the norepinephrinergic system in Parkinson\u2019s disease and related disorders: the locus coeruleus story. Neurochem Int 102:22\u201332","journal-title":"Neurochem Int"},{"issue":"3","key":"2221_CR152","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1007\/s11307-019-01418-2","volume":"22","author":"M Walker","year":"2020","unstructured":"Walker M, Kuebler L, Goehring CM, Pichler BJ, Herfert K (2020) Imaging SERT availability in a rat model of LDOPA-induced dyskinesia. Mol Imaging Biol 22(3):634\u2013642","journal-title":"Mol Imaging Biol"},{"key":"2221_CR153","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1054\/npep.2001.0875","volume":"35","author":"K Wilms","year":"2001","unstructured":"Wilms K, Vierig G, Davidowa H (2001) Interactive effects of cholecystokinin-8S and various serotonin receptor agonists on the firing activity of neostriatal neuronesin rats. Neuropeptides 35:257\u2013270. https:\/\/doi.org\/10.1054\/npep.2001.0875","journal-title":"Neuropeptides"},{"issue":"1","key":"2221_CR154","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/gt.2009.113","volume":"17","author":"YQ Xue","year":"2010","unstructured":"Xue YQ, Ma BF, Zhao LR, Tatom JB, Li B, Jiang LX, Duan WM (2010) AAV9-mediated erythropoietin gene delivery into the brain protects nigral dopaminergic neurons in a rat model of Parkinson\u2019s disease. Gene Ther 17(1):83\u201394","journal-title":"Gene Ther"},{"key":"2221_CR155","doi-asserted-by":"publisher","first-page":"614412","DOI":"10.3389\/fnins.2021.614412","volume":"15","author":"K Yang","year":"2021","unstructured":"Yang K, Zhao X, Wang C, Zeng C, Luo Y, Sun T (2021) Circuit mechanisms of L-DOPA-induced dyskinesia (LID). Front Neurosci 15:614412","journal-title":"Front Neurosci"},{"issue":"3","key":"2221_CR156","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.nbd.2010.08.004","volume":"40","author":"BY Zeng","year":"2010","unstructured":"Zeng BY, Iravani MM, Jackson MJ, Rose S, Parent A, Jenner P (2010) Morphological changes in serotoninergic neurites in the striatum and globus pallidus in levodopa primed MPTP treated common marmosets with dyskinesia. Neurobiol Dis 40(3):599\u2013607","journal-title":"Neurobiol Dis"},{"issue":"4","key":"2221_CR157","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1159\/000110318","volume":"12","author":"Z-X Zhang","year":"1993","unstructured":"Zhang Z-X, Rom\u00e1n GC (1993) Worldwide occurrence of Parkinson\u2019s disease: an updated review. Neuroepidemiology 12(4):195\u2013208. https:\/\/doi.org\/10.1159\/000110318","journal-title":"Neuroepidemiology"},{"key":"2221_CR158","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-8993(80)90250-4","volume":"186","author":"KD van der","year":"1980","unstructured":"van der KD, Hattori T (1980) Dorsal raphe cells with collateral projections to the caudate-putamen and substantia nigra: a fluorescent retrograde double labeling study in the rat. Brain Res 186:1\u20137","journal-title":"Brain Res"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-026-02221-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-026-02221-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-026-02221-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T07:02:09Z","timestamp":1776668529000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40478-026-02221-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,11]]},"references-count":158,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2221"],"URL":"https:\/\/doi.org\/10.1186\/s40478-026-02221-1","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,11]]},"assertion":[{"value":"23 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Human: Not applicable. Animal: All work involving animals was approved by the Institutional Animal Care and Use Committees at Barrow Neurological Institute, Binghamton University, and University of Illinois at Chicago.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"95"}}